Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

End-hole Versus Microvalve Infusion Catheters in Patients Undergoing Drug-Eluting Microspheres-TACE for Solitary Hepatocellular Carcinoma Tumors: A Retrospective Analysis.

Titano JJ, Fischman AM, Cherian A, Tully M, Stein LL, Jacobs L, Rubin RA, Bosley M, Citron S, Joelson DW, Shrestha R, Arepally A.

Cardiovasc Intervent Radiol. 2019 Apr;42(4):560-568. doi: 10.1007/s00270-018-2150-6. Epub 2019 Jan 11.

2.

Multivariate techniques enable a biochemical classification of children with autism spectrum disorder versus typically-developing peers: A comparison and validation study.

Howsmon DP, Vargason T, Rubin RA, Delhey L, Tippett M, Rose S, Bennuri SC, Slattery JC, Melnyk S, James SJ, Frye RE, Hahn J.

Bioeng Transl Med. 2018 Jun 19;3(2):156-165. doi: 10.1002/btm2.10095. eCollection 2018 May.

3.

Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo.

Frenette CT, Morelli G, Shiffman ML, Frederick RT, Rubin RA, Fallon MB, Cheng JT, Cave M, Khaderi SA, Massoud O, Pyrsopoulos N, Park JS, Robinson JM, Yamashita M, Spada AP, Chan JL, Hagerty DT.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):774-783.e4. doi: 10.1016/j.cgh.2018.06.012. Epub 2018 Jun 18.

4.

Local specialty pharmacy and specialty clinic collaboration assists access to hepatitis C direct-acting antivirals.

Zhu J, Hazen RJ, Joyce C, Delpino A, Kirkham HS, Strickland CD, Markes-Wilson S, Kim T, Kang M, Rubin RA, Stein LL.

J Am Pharm Assoc (2003). 2018 Jan - Feb;58(1):89-93.e2. doi: 10.1016/j.japh.2017.10.011. Epub 2017 Nov 16.

5.

Liver transplantation for fulminant genotype 2a/c hepatitis C virus marked by a rapid recurrence followed by cure.

Tracy B, Shrestha R, Stein L, Bhasin D, Pollinger H, Rubin RA.

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12690. Epub 2017 Apr 17.

PMID:
28273391
6.

Feasibility of collecting tumor samples of breast cancer patients diagnosed up to 50 years ago in the Child Health and Development Studies.

Krigbaum NY, Rubin RA, Cirillo PM, Terry MB, Habel LA, Morris C, Cohn BA.

J Dev Orig Health Dis. 2017 Jun;8(3):331-336. doi: 10.1017/S204017441700006X. Epub 2017 Mar 6.

PMID:
28260556
7.

Indole signalling and (micro)algal auxins decrease the virulence of Vibrio campbellii, a major pathogen of aquatic organisms.

Yang Q, Pande GSJ, Wang Z, Lin B, Rubin RA, Vora GJ, Defoirdt T.

Environ Microbiol. 2017 May;19(5):1987-2004. doi: 10.1111/1462-2920.13714. Epub 2017 Apr 3.

PMID:
28251783
8.

Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics Study.

Rubin RA, Russo MW, Brown KA, Fontana RJ, Levitsky J, Vargas H, Yoshida EM, Brown RS Jr.

Exp Clin Transplant. 2018 Apr;16(2):182-190. doi: 10.6002/ect.2016.0251. Epub 2016 Nov 18.

9.

Donor-Derived Hepatic Neuroendocrine Tumor: Pause Before Proceeding With Liver Retransplantation.

Al-Azzawi Y, Stein LL, Shrestha R, Bhasin D, Citron SJ, Rubin RA.

Transplant Direct. 2016 Jun 6;2(7):e88. eCollection 2016 Jul.

10.

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.

Sauer R, Hänsel M, Buhl R, Rubin RA, Frey M, Glaab T.

Int J Chron Obstruct Pulmon Dis. 2016 Apr 27;11:891-8. doi: 10.2147/COPD.S103023. eCollection 2016.

11.

Vibrio campbellii hmgA-mediated pyomelanization impairs quorum sensing, virulence, and cellular fitness.

Wang Z, Lin B, Mostaghim A, Rubin RA, Glaser ER, Mittraparp-Arthorn P, Thompson JR, Vuddhakul V, Vora GJ.

Front Microbiol. 2013 Dec 11;4:379. doi: 10.3389/fmicb.2013.00379. eCollection 2013.

12.

Behavioral-based physician interviewing.

Rubin RA.

Physician Exec. 2012 Nov-Dec;38(6):16-8, 20. No abstract available.

PMID:
23888647
13.

Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.

Sulkowski MS, Sherman KE, Dieterich DT, Bsharat M, Mahnke L, Rockstroh JK, Gharakhanian S, McCallister S, Henshaw J, Girard PM, Adiwijaya B, Garg V, Rubin RA, Adda N, Soriano V.

Ann Intern Med. 2013 Jul 16;159(2):86-96. doi: 10.7326/0003-4819-159-2-201307160-00654.

PMID:
23685940
14.

Patterning of regional gene expression in autism: new complexity.

Ginsberg MR, Rubin RA, Natowicz MR.

Sci Rep. 2013;3:1831. doi: 10.1038/srep01831.

15.

Toxicological status of children with autism vs. neurotypical children and the association with autism severity.

Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W.

Biol Trace Elem Res. 2013 Feb;151(2):171-80. doi: 10.1007/s12011-012-9551-1. Epub 2012 Nov 29.

PMID:
23192845
16.

Brain transcriptional and epigenetic associations with autism.

Ginsberg MR, Rubin RA, Falcone T, Ting AH, Natowicz MR.

PLoS One. 2012;7(9):e44736. doi: 10.1371/journal.pone.0044736. Epub 2012 Sep 12.

17.

Effect of a vitamin/mineral supplement on children and adults with autism.

Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W.

BMC Pediatr. 2011 Dec 12;11:111. doi: 10.1186/1471-2431-11-111.

18.

Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity.

Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W.

Nutr Metab (Lond). 2011 Jun 8;8(1):34. doi: 10.1186/1743-7075-8-34.

19.

Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity.

Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA.

BMC Gastroenterol. 2011 Mar 16;11:22. doi: 10.1186/1471-230X-11-22.

20.

Iron chelation by cranberry juice and its impact on Escherichia coli growth.

Lin B, Johnson BJ, Rubin RA, Malanoski AP, Ligler FS.

Biofactors. 2011 Mar-Apr;37(2):121-30. doi: 10.1002/biof.110. Epub 2010 Aug 30.

PMID:
20806417
21.

The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels.

Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr JM.

J Toxicol. 2009;2009:532640. doi: 10.1155/2009/532640. Epub 2009 Aug 26.

22.

Media acidification by Escherichia coli in the presence of cranberry juice.

Johnson BJ, Lin B, Rubin RA, Malanoski AP.

BMC Res Notes. 2009 Nov 12;2:226. doi: 10.1186/1756-0500-2-226.

23.

Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results.

Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J.

BMC Clin Pharmacol. 2009 Oct 23;9:17. doi: 10.1186/1472-6904-9-17.

24.

Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results.

Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J.

BMC Clin Pharmacol. 2009 Oct 23;9:16. doi: 10.1186/1472-6904-9-16.

25.

ABO incompatible liver transplantation as a bridge to treat HELLP syndrome.

Connor K, Rubin RA, Shrestha R, Johnson M, Sellers M, Butler B.

Gastroenterol Res Pract. 2009;2009:713937. doi: 10.1155/2009/713937. Epub 2009 Sep 28.

26.

A first principles approach to differential expression in microarray data analysis.

Rubin RA.

BMC Bioinformatics. 2009 Sep 16;10:292. doi: 10.1186/1471-2105-10-292.

27.

Impact of cranberry on Escherichia coli cellular surface characteristics.

Johnson BJ, Lin B, Dinderman MA, Rubin RA, Malanoski AP, Ligler FS.

Biochem Biophys Res Commun. 2008 Dec 19;377(3):992-4. doi: 10.1016/j.bbrc.2008.10.098. Epub 2008 Oct 26.

PMID:
18957286
28.

Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.

Saifee S, Joelson D, Braude J, Shrestha R, Johnson M, Sellers M, Galambos MR, Rubin RA.

Clin Gastroenterol Hepatol. 2008 Oct;6(10):1167-9. doi: 10.1016/j.cgh.2008.04.023. Epub 2008 Jul 17.

PMID:
18639498
29.

Are colonoscopies performed in private offices less likely to be successful?

Rubin RA, Galambos MR.

Gastroenterology. 2007 Oct;133(4):1390; author reply 1392. No abstract available.

PMID:
17919516
30.

Terbinafine-induced hepatic failure requiring liver transplantation.

Perveze Z, Johnson MW, Rubin RA, Sellers M, Zayas C, Jones JL, Cross R, Thomas K, Butler B, Shrestha R.

Liver Transpl. 2007 Jan;13(1):162-4.

31.

Outstanding scientist of the year 2006: Rogel Patawaran, BS.

Rubin RA, Hazirjian CL.

J Long Term Eff Med Implants. 2006;16(1):1-7.

PMID:
16566740
32.

Response to "Scientifically unsupported and supported interventions for childhood psychopathology: a summary".

Rubin R, Rubin RA.

Pediatrics. 2005 Jul;116(1):289; author reply 290-2. No abstract available.

PMID:
15995075
33.

Tyranny of algorithms in the treatment of patients with hepatitis C.

Rubin RA.

Hepatology. 2003 Dec;38(6):1593-4; author reply 1594-5. No abstract available.

PMID:
14647072
34.
35.

Role of screening colonoscopy in elective liver transplantation evaluation.

Selingo JA, Herrine SK, Weinberg DS, Rubin RA.

Transplant Proc. 1997 Aug;29(5):2506-8. No abstract available.

PMID:
9270827
36.

Evaluation of the solid hepatic mass.

Rubin RA, Mitchell DG.

Med Clin North Am. 1996 Sep;80(5):907-28. Review.

PMID:
8804368
37.

Images in clinical medicine. Giant esophageal ulcers.

Rubin RA, Levine MS.

N Engl J Med. 1996 Apr 18;334(16):1029. No abstract available.

38.

Post-transfusion acquired malaria complicating orthotopic liver transplantation.

Talabiska DG, Komar MJ, Wytock DH, Rubin RA.

Am J Gastroenterol. 1996 Feb;91(2):376-9.

PMID:
8607511
39.

Nuclear imaging of solid hepatic masses.

Kinnard MF, Alavi A, Rubin RA, Lichtenstein GR.

Semin Roentgenol. 1995 Oct;30(4):375-95. Review.

PMID:
8539646
40.

Fatal Vibrio parahemolyticus septicemia in a patient with cirrhosis. A case report and review of the literature.

Hally RJ, Rubin RA, Fraimow HS, Hoffman-Terry ML.

Dig Dis Sci. 1995 Jun;40(6):1257-60. Review.

PMID:
7781443
41.

Fast three-dimensional time-of-flight MR angiography of the intra-cranial vasculature.

Talagala SL, Jungreis CA, Kanal E, Meyers SP, Foo TK, Rubin RA, Applegate GR.

J Magn Reson Imaging. 1995 May-Jun;5(3):317-23.

PMID:
7633109
42.

Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores.

Rubin RA, Haskal ZJ, O'Brien CB, Cope C, Brass CA.

Am J Gastroenterol. 1995 Apr;90(4):556-63.

PMID:
7717310
43.

Treatment of refractory anorectal variceal bleeding.

Rubin RA, Munoz SJ.

Gastroenterology. 1995 Apr;108(4):1332. No abstract available.

PMID:
7698610
44.

Ursodiol for hepatobiliary disorders.

Rubin RA, Kowalski TE, Khandelwal M, Malet PF.

Ann Intern Med. 1994 Aug 1;121(3):207-18. Review.

PMID:
8017748
45.

Intestinal varices: treatment with the transjugular intrahepatic portosystemic shunt.

Haskal ZJ, Scott M, Rubin RA, Cope C.

Radiology. 1994 Apr;191(1):183-7.

PMID:
8134568
46.

Chronic hepatitis C. Advances in diagnostic testing and therapy.

Rubin RA, Falestiny M, Malet PF.

Arch Intern Med. 1994 Feb 28;154(4):387-92. Review.

PMID:
7509593
47.
48.

Recurrent bleeding from anorectal varices: successful treatment with a transjugular intrahepatic portosystemic shunt.

Katz JA, Rubin RA, Cope C, Holland G, Brass CA.

Am J Gastroenterol. 1993 Jul;88(7):1104-7.

PMID:
8317414
49.

Scintigraphic evaluation of liver masses: cavernous hepatic hemangioma.

Rubin RA, Lichtenstein GR.

J Nucl Med. 1993 May;34(5):849-52.

50.

Hepatic scintigraphy in the evaluation of solitary solid liver masses.

Rubin RA, Lichtenstein GR.

J Nucl Med. 1993 Apr;34(4):697-705. Review. No abstract available.

Supplemental Content

Loading ...
Support Center